# Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

> clinical trial · VERIFIED · 2026-08-18

Status: ENROLLING_BY_INVITATION · Sponsor: Endogenex, Inc. · Condition: Type 2 Diabetes Mellitus

- Company: Endogenex, Inc.
- Sector: medical devices
- Primary source: https://clinicaltrials.gov/study/NCT07197788

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.